What’s Next? Five Things To Look Out For In September
Alvotech Likely To Hear From USFDA On Humira Biosimilar
In the month ahead, Alvogen’s biosimilars sister company Alvotech is anticipated to receive a USFDA decision on its biosimilar Humira candidate, while Hikma’s management will meet investors to discuss prospects for its Generics business.
